Author:
Chondrou Vasiliki,Stavrou Eleana F.,Markopoulos Georgios,Kouraklis-Symeonidis Alexandra,Fotopoulos Vasilios,Symeonidis Argiris,Vlachaki Efthymia,Chalkia Panagiota,Patrinos George P.,Papachatzopoulou Adamantia,Sgourou Argyro
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Genetics,Molecular Biology,Molecular Medicine
Reference47 articles.
1. Taher AVE, Musallam K, Cappellini MD, Viprakasit V. Guidelines for the management of non transfusion dependent thalassaemia (NTDT). Nicosia Cyprus: Thalassaemia International Federation; 2013.
2. Giannopoulou E, Bartsakoulia M, Tafrali C, Kourakli A, Poulas K, Stavrou EF, et al. A single nucleotide polymorphism in the HBBP1 gene in the human beta-globin locus is associated with a mild beta-thalassemia disease phenotype. Hemoglobin. 2012;36(5):433–45.
https://doi.org/10.3109/03630269.2012.717515
.
3. Lessard S, Beaudoin M, Benkirane K, Lettre G. Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors. Genome Med. 2015;7(1):1.
https://doi.org/10.1186/s13073-014-0122-2
.
4. Lavelle DE. The molecular mechanism of fetal hemoglobin reactivation. Semin Hematol. 2004;41(4 Suppl 6):3–10.
5. Gravia A, Chondrou V, Sgourou A, Papantoni I, Borg J, Katsila T, et al. Individualizing fetal hemoglobin augmenting therapy for beta-type hemoglobinopathies patients. Pharmacogenomics. 2014;15(10):1355–64.
https://doi.org/10.2217/pgs.14.101
.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献